Strong topline growth masking margin pressure from commodity headwinds
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 6/10
Grade B
Hit prior double-digit revenue guidance; margin guidance being walked down cautiously (24% → 20-22%); subsidiaries still loss-making
Cautiously Optimistic
next 1–2 quarters
Optimistic
multi-year
Strong revenue delivery (+25% YoY) and near-term growth drivers (Bushing 35%, Stamping 31%, CapEx ramp) offset by PAT decline despite topline growth and aggressive FY27 targets. Margin recovery hinges on RM pass-through timing and Advantek needing 3.25x growth in 9 months.
₹457.4 Cr
Revenue · +25.2% YoY₹37.4 Cr
Reported PAT · −1.5% YoYCompressing
Margins · vs guidance: MixedDid the claims hold up?
Satisfactory Q1 performance in line with management plan
OVERSTATEDRevenue +25% YoY exceeded guidance; PAT flat/down -1.5% despite topline growth
Pass-through of 8% RM increase will normalize margins in Q2
PartialOPM fell 150 bps YoY; margin recovery timing unverified, dependent on customer acceptance
Strong 21% growth in India Engineering with 6% QoQ growth
METConfirmed; India segment delivered 21% YoY and 6% QoQ despite macro headwinds
Bushing targeting 30% growth FY27 with strong visibility
METQ1 delivered 35% YoY; but order book and pipeline assurances lack specifics
Advantek ₹140 Cr+ revenue target for FY27
MISSQ1 ₹30 Cr, FY26 ₹43 Cr; requires 3.25x growth in 3 quarters, highly aggressive
Earnings quality
What changed since the last call
India guidance upgraded to high-teens
UpgradePrior mid-teens (14-15%), now high-teens (16%+); Q1 delivered 21% supports upgrade but Q4 FY26 was typically strongest
Japan customer growth downgraded to 10%
DowngradeQ1 showed 25% growth (₹21 Cr) but full-year guidance capped at 10% (₹80 Cr); management cited slow project pipeline
Margin guidance narrowed to 20-22% band
DowngradeStandalone Q1 was 24%; new guidance reflects RM cost impact and capex ramp costs; prior was 'maintain current profile'
Romania losses timeline pushed
NeutralCombined China + Romania target of ₹2-3 Cr loss from ₹10 Cr in FY26; breakeven now 'maybe next year' vs prior expectation
The Q&A
Q&A was pointed: analysts pressed on Romania's path to profitability (management hedged with 'gradually reduce losses'), large-Cages Q1 weakness (blamed capacity ramp), and Japan guidance downgrade (acknowledged 'laggard in terms of growth'). Management held firm on targets but offered minimal specificity on subsidiary recovery mechanics.
Revenue growth drivers — Varun Jain, Dolat Capital
AnsweredBroad-based: industrial demand strengthening globally + European recovery. Growth across all segments.
FY27 growth guidance — Varun Jain, Dolat Capital
AnsweredNo, 20% is very tough stretch. Mid-to-high-teens India, low-teens consolidated expected.
Margin compression — Varun Jain, Dolat Capital
AnsweredAcross the board: brass, copper, zinc, steel, polymer. Global conditions impacted all materials.
Foreign subsidiary margins — Varun Jain, Dolat Capital
PartialRM costs continuing to rise, negating revenue upside. Romania FX loss ₹2 Cr also impacted.
Romania recovery plan — Amit Anwani, PL Capital
PartialWorking on it but limited numbers so far. Pipeline improving toward cages; combined loss ₹2-3 Cr by FY27 end target.
Bushing growth sustainability — Amit Anwani, PL Capital
AnsweredConversion effect + wallet share. Expect conversion to continue 1-2 years; addition of new products also supporting.
Large-size Cages weakness — Amit Anwani, PL Capital
AnsweredQ1 was aberration due to capacity ramp-up at new facility. Strong order book and pipeline support 50% confidence.
CapEx progress update — Vaibhav Shah, Equirus Securities
AnsweredChina Phase-2 on track for Q3 FY28 commissioning. Bhayla Phase-2 construction rolling; expect ₹50-80 Cr this year.
Core Cages growth (excl. new products) — Manish Goyal, ThinkWise
AnsweredYes, driven by Indian economy growth + outsourcing + customer export plants. Should match bearing industry growth 10%+ at least.
Japan customer guidance — Varun Jain, Dolat Capital
PartialLast year ₹72 Cr; expect same run-rate continue, so ₹80 Cr = ~10%. Japan very slow; many projects under discussion.
Solar business volatility — Varun Jain, Dolat Capital
AnsweredProject-based business; Q4 typically strong (depreciation benefit). FY27 revenue ₹200 Cr ~₹7-8% EBITDA margin.
Customer concentration — Varun Jain, Dolat Capital
AnsweredAll named are top customers. Top 10 customers ~80% of revenue spread across 80+ plants globally. High wallet share 80-90% with major customers.
Advantek margin expectations — Uttam Purohit, VVD Asset Mgmt
AnsweredQ1 ~9% (impacted by material costs). Will match India EBITDA margin next year. Currently in ramp phase.
China delay implications — Varun Jain, Dolat Capital
AnsweredChina will see low growth in FY28; benefit accelerates from FY29 onward.
Margin recovery path — Jason Soans, IDBI Capital
AnsweredYes, RM costs will reduce margin percentage despite absolute value increase; also capex ramp-up costs impact FY27.
PAT outgrowth thesis — Resham Jain, VBD Asset Mgmt
AnsweredYes, especially this year. Q-o-Q Advantek losses will reduce dramatically; if Romania turns around, even more leverage.
Guidance
FY27 India high-teens growth (upgraded from mid-teens)
HighQ1 delivered 21% YoY supports high-teens; driven by Bushing 30%, Stamping 30%, core Cages 10%+ growth
FY27 consolidated low-to-medium teens growth
Medium10-15% band; India high-teens + foreign low single-digit (China 10%, Romania <10%) blends to low-teens
Advantek ₹140 Cr+ revenue FY27 (vs ₹43 Cr FY26)
LowRequires 3.25x growth in 9 months; Q1 only ₹30 Cr; management confident but execution risk high
Bushing 30% growth FY27 (base ₹127 Cr FY26)
HighQ1 ₹34 Cr (+35% YoY); strong visibility on orders; conversion effects expected to continue 1-2 years
Stamping 30% growth FY27 (base ₹60 Cr FY26)
HighQ1 ₹90 Cr (inconsistent with base; likely includes new products); new product pipeline strong (AC, railways)
India margin 20-22% sustainable (vs 24% Q1 standalone)
MediumAssumes RM pass-through in Q2-Q3; also incorporates capex ramp costs; lag risk if pass-through delayed
Consolidated EBITDA 18% expected (vs 16% Q1)
MediumDepends on metal price stabilization; management noted if stable, margin reverts to prior 18.7%
China EBITDA 12-14% range; PAT ~6%
HighStable margins demonstrated; Brownfield expansion expected to maintain similar profile
FY27 CapEx ₹50-80 Cr (Q1 ₹37 Cr)
HighBhayla Phase-2 + China Phase-2 + regular maintenance; total ₹180-200 Cr over 2 years announced
Risks the call surfaced
Margin recovery timing
HighRM pass-through lag extends margin pressure into H2 FY27; customer price resistance or competitive dynamics may prevent full recovery; OPM down 150 bps YoY.
Advantek ramp-up execution
High₹140 Cr FY27 revenue target requires ~₹35 Cr/qtr burn-rate from current ₹30 Cr; PAT positive by FY27-end unproven; Phase-2 capex announced before Phase-1 fully ramped.
Romania profitability path
HighLosses continue despite topline growth; new management/strategy still in early stage; breakeven timeline pushed to 'maybe next year' (unverified); ₹2 Cr FX loss in Q1 masks operational issues.
Large-Cages ramp slowness
MediumQ1 only ₹10 Cr despite 50% FY27 growth target; new facility ramping slower than expected; high-value segment at risk if ramp delays persist.
Japan customer deceleration
MediumQ1 ₹21 Cr (+25% YoY) but FY27 guidance only 10% (₹80 Cr); slow project pipeline acknowledged; development conversion cycle lengthy unverified.
Management
Score 7/10. Transparent on headwinds (FX ₹4 Cr, RM ₹8 Cr, war ₹3 Cr); specific cost impacts quantified. Somewhat opaque on China/Romania separate financials (consolidated reporting). Credible on timing lag explanations. Hit prior double-digit revenue guidance; met/beat key product growth targets (Bushing 35%, Stamping 31%). Margin guidance walked down cautiously (24% → 20-22%), showing realism. Advantek and subsidiary recovery track record unproven.
1 · Q2 FY27 (Oct 2026)
RM cost pass-through impact visible; margin recovery signal
2 · H2 FY27
Advantek ramp accelerates toward ₹140 Cr annual run-rate target
3 · Q3 FY28
China brownfield expansion commissioned; FY29 full impact
Margin recovery hinges on RM pass-through timing and Advantek needing 3.25x growth in 9 months.
Informational and educational content only. Not investment advice.